Trial intelligence / Profile preview

GLPG1972 in Knee Osteoarthritis (ROCCELLA)

NCT03595618Phase 2Completed

Sponsor
Galapagos NV
Start
Aug 2018
Primary completion
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of GLPG1972 in knee osteoarthritis (OA), sponsored by Galapagos NV. Started Aug 2018; status: completed.

02

Drugs

GLPG1972
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT03595618.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03595618.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call